Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Detection of immunogenic cell death and its relevance for cancer therapy

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer